Talmadge King is a Respiratory physician affiliated with University of California, San Francisco. OpenAlex indexes 307 publications with 58,236 citations (h-index 106); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 1% of Pulmonary Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
505 Parnassus Ave
M-994
San Francisco, CA 941430120
Telephone
415-476-0909Registry record last updated 8 May 2015.
Clinical trials
- AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
Sponsor: Duke University
- Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis
Sponsor: Duke University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
1 NIH research award on record, funded 2005–2009 per NIH RePORTER. The latest:
- Idiopathic Pulmonary Fibrosis Clinical Research Network
University of California, San Francisco
FY2009$191,220U10HL080685 - Idiopathic Pulmonary Fibrosis Clinical Research Network
University of California, San Francisco
FY2008$183,907U10HL080685 - Idiopathic Pulmonary Fibrosis Clinical Research Network
University of California, San Francisco
FY2007$183,520U10HL080685
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials
European Respiratory Journal
2015 - A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
New England Journal of Medicine
2014 - An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
American Journal of Respiratory and Critical Care Medicine
2013
Similar KOLs
Other experts from the same institution or the same specialty.
Kristine Yaffe, MD
University of California, San Francisco
Peter Carroll, MD
University of California, San Francisco
Mitchel Berger, MD
University of California, San Francisco
Elyse Foster, MD
University of California, San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”